The percentage of patients who died in the group not treated with statins was 25.4%, whereas it was 19.8% among those who were, which is to say, the treatment group had 22% lower mortality. "The data indicate that treatment with statins prevents one in five deaths," indicated Masana. Furthermore, if treatment with this medicine continued during hospitalization, mortality fell by up to 25%, thus preventing one in four deaths.
Consequently, Lluís Masana went on to say that "not only do these findings demonstrate that treatment with statins has no negative on the evolution of COVID-19, they also show that it significantly reduces patient mortality."
